Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy
T Zhong, J Yu, Y Pan, N Zhang, Y Qi… - Advanced Healthcare …, 2023 - Wiley Online Library
Platinum drugs with manifest therapeutic effects are widely used, but their systemic toxicity
and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the …
and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the …
Recent advances of platinum-based anticancer complexes in combinational multimodal therapy
T Zhong, J Yu, Y Pan, N Zhang, Y Qi… - Advanced healthcare … - pubmed.ncbi.nlm.nih.gov
Platinum drugs with manifest therapeutic effects are widely used, but their systemic toxicity
and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the …
and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the …
Recent advances of platinum-based anticancer complexes in combinational multimodal therapy.
T Zhong, J Yu, Y Pan, N Zhang, Y Qi… - Advanced Healthcare …, 2023 - europepmc.org
Platinum drugs with manifest therapeutic effects are widely used, but their systemic toxicity
and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the …
and the drug resistance acquired by cancer cells limit their clinical applications. Thus, the …